Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
344.75
-23.10 (-6.28%)
At close: Aug 28, 2026, 4:00 PM EDT
346.00
+1.25 (0.36%)
After-hours: Aug 28, 2026, 7:57 PM EDT
PRAX Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, PRAX stock has a consensus rating of "Strong Buy" and an average price target of $638.68. The average 1-year stock price forecast is 85.26% higher than the current stock price, while the lowest is $188 (-45.47%) and the highest is $1,201 (+248.37%).
Price Target: $638.68 (+85.26%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 13 | 13 | 14 | 14 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 16 | 17 | 17 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Reiterates $470 → $575 | Buy | Reiterates | $470 → $575 | +66.79% | Aug 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $650 | Buy | Reiterates | $650 | +88.54% | Aug 18, 2026 |
| Raymond James | Raymond James | Buy Maintains $765 → $945 | Buy | Maintains | $765 → $945 | +174.11% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1,201 | Buy | Reiterates | $1,201 | +248.37% | Aug 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,200 | Buy | Maintains | $1,200 | +248.08% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
876.86K
Revenue Next Year
348.03M
from 876.86K
Increased by 39,590.53%
EPS This Year
-13.94
from -13.48
EPS Next Year
-9.29
from -13.94
EPS and Forward PE are based on non-GAAP adjusted numbers.